We provide you with 20 years of free, institutional-grade data for NTLA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NTLA. Explore the full financial landscape of NTLA stock.
Total insider purchase within 3 month on this page: $1,002,999
Total insider selling within 3 month on this page: -$104,617
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| CHASE WILLIAM J | Open Market Purchase | 100,000 | $10.03 | 2025-08-22 | |
| Dulac Edward J III | Sale | -7,462 | $14.02 | $104,617 | 2025-07-25 |
| Clark Eliana | Sale | -1,022 | $9.82 | $10,036 | 2025-07-03 |
| Dube Michael P | Sale | -2,503 | $9.95 | $24,905 | 2025-07-03 |
| GOODMAN JESSE | Sale | -3,094 | $9.56 | $29,579 | 2025-07-02 |
| Keresty Georgia | Grant, award...etc | 8,000 | 2025-06-18 | ||
| CHASE WILLIAM J | Grant, award...etc | 8,000 | 2025-06-13 | ||
| Cohen Fred E | Grant, award...etc | 8,000 | 2025-06-13 | ||
| Verwiel Frank | Grant, award...etc | 8,000 | 2025-06-13 | ||
| GOODMAN JESSE | Grant, award...etc | 8,000 | 2025-06-13 | ||
| Bhanji Muna | Grant, award...etc | 8,000 | 2025-06-13 | ||
| Goff Brian | Grant, award...etc | 8,000 | 2025-06-13 | ||
| Bhanji Muna | Sale | -265 | $8.5 | $2,253 | 2025-05-01 |
| Lebwohl David | Grant, award...etc | 43,200 | 2025-03-04 | ||
| BASTA JAMES | Sale | -2,572 | $8.99 | $23,122 | 2025-03-04 |
| BASTA JAMES | Grant, award...etc | 40,000 | 2025-03-04 | ||
| Schultes Birgit C | Grant, award...etc | 37,600 | 2025-03-04 | ||
| Dulac Edward J III | Grant, award...etc | 47,200 | 2025-03-04 | ||
| Dube Michael P | Grant, award...etc | 14,000 | 2025-03-04 | ||
| Clark Eliana | Sale | -679 | $8.99 | $6,104 | 2025-03-04 |
| Clark Eliana | Grant, award...etc | 32,000 | 2025-03-04 | ||
| LEONARD JOHN M | Grant, award...etc | 136,000 | 2025-03-04 | ||
| Bhanji Muna | Sale | -265 | $9.97 | $2,642 | 2025-01-31 |
| Schultes Birgit C | Initial | 2025-01-23 | |||
| Sepp-Lorenzino Laura | Sale | -8,966 | $12.18 | $109,206 | 2025-01-07 |
| LEONARD JOHN M | Sale | -26,807 | $12.18 | $326,509 | 2025-01-07 |
| Dube Michael P | Sale | -1,372 | $12.18 | $16,711 | 2025-01-07 |
| Lebwohl David | Sale | -9,557 | $12.18 | $116,404 | 2025-01-07 |
| Hicks Derek | Sale | -6,502 | $12.18 | $79,194 | 2025-01-07 |
| BASTA JAMES | Sale | -7,074 | $12.18 | $86,161 | 2025-01-07 |
| Clark Eliana | Sale | -7,978 | $12.03 | $95,975 | 2025-01-06 |
| Lebwohl David | Derivatives Exercise | 3,189 | 2025-01-03 | ||
| Lebwohl David | RSU | 3,189 | 2025-01-03 | ||
| Sepp-Lorenzino Laura | Derivatives Exercise | 3,500 | 2025-01-03 | ||
| Sepp-Lorenzino Laura | RSU | 3,500 | 2025-01-03 | ||
| LEONARD JOHN M | Derivatives Exercise | 7,850 | 2025-01-03 | ||
| LEONARD JOHN M | RSU | 7,850 | 2025-01-03 | ||
| Dube Michael P | Sale | -2,012 | $19.01 | $38,248 | 2024-10-04 |
| Dulac Edward J III | Grant, award...etc | 66,324 | 2024-07-24 | ||
| Dube Michael P | Grant, award...etc | 17,801 | 2024-07-03 | ||
| Clark Eliana | Sale | -405 | $22.93 | $9,287 | 2024-07-03 |
| Verwiel Frank | Sale | -1,505 | $25 | $37,625 | 2024-06-20 |
| Goff Brian | Grant, award...etc | 15,409 | 2024-06-17 | ||
| Bhanji Muna | Grant, award...etc | 7,737 | 2024-06-14 | ||
| Cohen Fred E | Grant, award...etc | 7,737 | 2024-06-14 | ||
| CHASE WILLIAM J | Grant, award...etc | 7,737 | 2024-06-14 | ||
| Keresty Georgia | Grant, award...etc | 7,737 | 2024-06-14 | ||
| GOODMAN JESSE | Grant, award...etc | 7,737 | 2024-06-14 | ||
| Verwiel Frank | Grant, award...etc | 7,737 | 2024-06-14 | ||
| Dube Michael P | Initial | 2024-04-22 | |||
| LEONARD JOHN M | Grant, award...etc | 113,586 | 2024-03-05 | ||
| Lebwohl David | Grant, award...etc | 38,701 | 2024-03-05 | ||
| Goddard Glenn | Grant, award...etc | 28,628 | 2024-03-05 | ||
| Hicks Derek | Grant, award...etc | 29,393 | 2024-03-05 | ||
| Sepp-Lorenzino Laura | Grant, award...etc | 37,966 | 2024-03-05 | ||
| Clark Eliana | Sale | -605 | $32.99 | $19,959 | 2024-03-05 |
| Clark Eliana | Grant, award...etc | 31,230 | 2024-03-05 | ||
| BASTA JAMES | Sale | -2,297 | $32.99 | $75,778 | 2024-03-05 |
| BASTA JAMES | Grant, award...etc | 32,394 | 2024-03-05 | ||
| Sepp-Lorenzino Laura | Sale | -2,275 | $28.66 | $65,202 | 2024-01-10 |
| Goddard Glenn | Sale | -5,365 | $29.46 | $158,053 | 2024-01-05 |
| Lebwohl David | Sale | -5,843 | $29.46 | $172,135 | 2024-01-05 |
| Sepp-Lorenzino Laura | Sale | -5,532 | $29.46 | $162,973 | 2024-01-05 |
| Hicks Derek | Sale | -3,877 | $29.46 | $114,216 | 2024-01-05 |
| Clark Eliana | Sale | -4,608 | $30.12 | $138,793 | 2024-01-05 |
| BASTA JAMES | Sale | -3,805 | $29.46 | $112,095 | 2024-01-05 |
| LEONARD JOHN M | Sale | -19,223 | $29.46 | $566,310 | 2024-01-05 |
| Sepp-Lorenzino Laura | Derivatives Exercise | 3,500 | 2024-01-03 | ||
| Sepp-Lorenzino Laura | RSU | 3,500 | 2024-01-03 | ||
| LEONARD JOHN M | Derivatives Exercise | 7,848 | 2024-01-03 | ||
| LEONARD JOHN M | RSU | 7,848 | 2024-01-03 | ||
| Lebwohl David | Derivatives Exercise | 3,187 | 2024-01-03 | ||
| Lebwohl David | RSU | 3,187 | 2024-01-03 | ||
| Goddard Glenn | Derivatives Exercise | 3,062 | 2024-01-03 | ||
| Goddard Glenn | RSU | 3,062 | 2024-01-03 | ||
| Bhanji Muna | Sale | -265 | $23.9 | $6,334 | 2023-11-02 |
| Bhanji Muna | Sale | -265 | $42.33 | $11,217 | 2023-08-02 |
| Bhanji Muna | Sale | -1,867 | $39.3 | $73,373 | 2023-07-10 |
| Clark Eliana | Sale | -360 | $40.51 | $14,584 | 2023-07-06 |
| Clark Eliana | Sale | -5,000 | $45 | $225,000 | 2023-06-22 |
| Clark Eliana | Derivatives Exercise | 5,000 | 2023-06-22 | ||
| Bhanji Muna | Grant, award...etc | 4,425 | 2023-06-16 | ||
| Crowley John F | Grant, award...etc | 4,425 | 2023-06-16 | ||
| Cohen Fred E | Grant, award...etc | 4,425 | 2023-06-16 | ||
| CHASE WILLIAM J | Grant, award...etc | 1,673 | 2023-06-16 | ||
| Verwiel Frank | Grant, award...etc | 4,425 | 2023-06-16 | ||
| Keresty Georgia | Grant, award...etc | 4,425 | 2023-06-16 | ||
| GOODMAN JESSE | Grant, award...etc | 4,425 | 2023-06-16 | ||
| CHASE WILLIAM J | Grant, award...etc | 10,483 | 2023-04-18 | ||
| CHASE WILLIAM J | Initial | 2023-04-18 | |||
| BASTA JAMES | Sale | -1,088 | $43.88 | $47,741 | 2023-03-03 |
| BASTA JAMES | Grant, award...etc | 36,808 | 2023-03-03 | ||
| Sepp-Lorenzino Laura | Grant, award...etc | 29,938 | 2023-03-03 | ||
| Clark Eliana | Grant, award...etc | 30,673 | 2023-03-03 | ||
| Lebwohl David | Grant, award...etc | 30,674 | 2023-03-03 | ||
| Hicks Derek | Grant, award...etc | 23,558 | 2023-03-03 | ||
| Goddard Glenn | Grant, award...etc | 27,484 | 2023-03-03 | ||
| LEONARD JOHN M | Grant, award...etc | 91,036 | 2023-03-03 | ||
| LEONARD JOHN M | Sale | -6,673 | $37.21 | $248,302 | 2023-01-06 |
| Sepp-Lorenzino Laura | Sale | -4,838 | $37.21 | $180,022 | 2023-01-06 |
| Hicks Derek | Sale | -1,812 | $37.21 | $67,425 | 2023-01-06 |
| Lebwohl David | Sale | -2,574 | $37.21 | $95,779 | 2023-01-06 |
| Goddard Glenn | Sale | -2,427 | $37.21 | $90,309 | 2023-01-06 |
| Clark Eliana | Sale | -2,028 | $51.74 | $104,929 | 2023-01-06 |
| BASTA JAMES | Sale | -1,138 | $37.21 | $42,345 | 2023-01-06 |
| Lebwohl David | Derivatives Exercise | 3,187 | 2023-01-04 | ||
| Lebwohl David | RSU | 3,187 | 2023-01-04 | ||
| Sepp-Lorenzino Laura | Derivatives Exercise | 3,500 | 2023-01-04 | ||
| Sepp-Lorenzino Laura | RSU | 3,500 | 2023-01-04 | ||
| LEONARD JOHN M | Derivatives Exercise | 7,848 | 2023-01-04 | ||
| LEONARD JOHN M | RSU | 7,848 | 2023-01-04 | ||
| Goddard Glenn | Derivatives Exercise | 3,062 | 2023-01-04 | ||
| Goddard Glenn | RSU | 3,062 | 2023-01-04 | ||
| Verwiel Frank | Grant, award...etc | 5,197 | 2022-06-16 | ||
| Crowley John F | Grant, award...etc | 5,197 | 2022-06-16 | ||
| GOODMAN JESSE | Grant, award...etc | 5,197 | 2022-06-16 | ||
| DORSA CAROLINE | Grant, award...etc | 5,197 | 2022-06-16 | ||
| FORMELA JEAN FRANCOIS | Grant, award...etc | 5,197 | 2022-06-16 |
The information provided in this report about NTLA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Intellia Therapeutics, Inc(NASDAQ:NTLA) 
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. It utilizes a biological tool known as the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. The company's in vivo programs include NTLA-2001, which i...
Website: http://www.intelliatx.com
Founded: 2014
Full Time Employees: 270
CEO: John Leonard
Sector: Healthcare
Industry: Biotechnology